🔎 Trials Near Me

Beranda › Kanker Darah › Illinois › Chicago

Uji klinis Kanker Darah di Chicago, IL

15 studi untuk Kanker Darah mencari peserta di lokasi sekitar Chicago (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.

Teks studi resmi (Bahasa Inggris)

Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →

Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)

Menerima pesertaFase 3
  • The University of Chicago ( Site 0020), Chicago
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT03486873

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Menerima pesertaStudi observasionalSukarelawan sehat diterima
  • Mount Sinai Hospital Medical Center, Chicago
  • John H Stroger Jr Hospital of Cook County, Chicago
  • University of Illinois, Chicago
  • dan 1 lainnya
Usia 40 hingga 75 · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT05334069

Collection of Research Data and Samples From Patients Treated With Immunotherapy to Study Its Side Effects

Menerima pesertaStudi observasional
  • Swedish Covenant Hospital, Chicago
  • Advocate Illinois Masonic Medical Center, Chicago
Semua usia · Semua jenis kelamin · Diperbarui 17 Sep 2026 · NCT04242095

Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia

Menerima pesertaFase 1
  • Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 20 Agu 2026 · NCT06001788

Tempus Open Link for Individual Voices in Innovative Analytics Registry: Platform Protocol for Multimodal Real-World Evidence in Cancer

Menerima pesertaStudi observasionalSukarelawan sehat diterima
  • Tempus AI, Chicago
Semua usia · Semua jenis kelamin · Diperbarui 10 Agu 2026 · NCT07756034

Mosaic Trial for Stem Cell Transplant Recipients

Menerima peserta
  • Northwestern University Feinberg School of Medicine, Chicago
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 3 Agu 2026 · NCT06960993

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

Menerima pesertaStudi observasional
  • Northwestern Memorial Hospital, Chicago
  • Rush University Medical Center, Chicago
  • University of Illinois at Chicago, Chicago
  • dan 2 lainnya
Semua usia · Semua jenis kelamin · Diperbarui 6 Jul 2026 · NCT01351545

An Extension Study for Patients Previously Enrolled in Studies With Pelabresib

Menerima pesertaFase 3
  • Northwestern University, Chicago
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 11 Jun 2026 · NCT06401356

Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CMML-2, MPN-BP, ALL, MF, NHL, RT, MM or T-PLL.

Menerima pesertaFase 1
  • University of Chicago, Chicago
Usia 13 ke atas · Semua jenis kelamin · Diperbarui 5 Mei 2026 · NCT04771572

CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)

Menerima pesertaFase 1/2
  • Northwestern Memorial Hospital, Chicago
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 16 Apr 2026 · NCT03328078

A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML

Menerima pesertaFase 1
  • Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 13 Mar 2026 · NCT05735184

Leukemia and Lymphoma Society (LLS) Services Impact on Outcomes and Care

Menerima peserta
  • University of Chicago Comprehensive Cancer Center, Chicago
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 20 Feb 2026 · NCT05745285

Study to Evaluate the Pharmacokinetics and Safety of Pralatrexate in Patients With Advanced Solid Tumor or Hematological Malignancy and Either Normal Hepatic Function or Mild, Moderate, or Severe Hepatic Impairment

Menerima pesertaFase 1
  • Northwestern University - Feinberg School of Medicine, Chicago
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 11 Feb 2026 · NCT07036133

MPN PROGRESSion Registry: Observational Study Tracking Symptoms, Treatments, and Disease Progression in People With Myeloproliferative Neoplasms (MPNs)

Menerima pesertaStudi observasional
  • MPN Research Foundation, Chicago
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 23 Jan 2026 · NCT07362225

Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies

Menerima pesertaFase 1
  • Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
Usia 1 hingga 21 · Semua jenis kelamin · Diperbarui 6 Des 2024 · NCT05476770

Uji klinis Kanker Darah di kota lain

Studi lain di Chicago

Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.